The results showed that patients in the MDMA groups experienced a more significant reduction in PTSD symptom severity compared to those in the placebo groups. The FDA Advisory Committee expressed ...

The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

Poulter said the study, compiled by research clinics around the world, clearly demonstrated the benefits of what’s known as MDMA-assisted therapy for PTSD. It involves taking the drug three ...

After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for ...

MDMA-assisted psychotherapy has been shown to be a safe and effective treatment for PTSD and complex trauma. Why did the FDA ...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...

More than 70 percent of the MDMA group no longer qualified for a PTSD diagnosis, compared to 48 percent of the control group. The FDA's advisers worried that the negative effects of MDMA-assisted ...

FDA Rejects MDMA-AT for PTSD, but Lykos Vows to Push On Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and ...

Brain damage that veterans suffered from flying shrapnel has provided a major clue that could lead to better treatment for ...

There’s been a lot of news recently about the use of MDMA ... adult-onset PTSD and complex PTSD stemming from prolonged childhood trauma. The bad news? The U.S. Food and Drug Administration ...